ÂÜÀòÂÒÂ×

Yannik Schmidt is currently a Research Associate at Numab Therapeutics AG, with previous experience as an Intern at Universitätsspital Basel. Yannik completed a Master of Science in Drug Sciences at the University of Basel, following a Bachelor of Science in Pharmazeutische Wissenschaften at the same university. Yannik presented their research on radiolabeling and preclinical evaluation of a new class of radiopharmaceuticals at the 34th Annual Congress of the European Association of Nuclear Medicine.